/Home/USA/Psychedelics Law in USA - Nationwide/Yetter Coleman LLP
View profile of Yetter Coleman LLP
Department profile
Yetter Coleman LLP
Department profile | Yetter Coleman LLP
Psychedelics Law

Chambers Review

Provided by Chambers

Psychedelics Law - USA - Nationwide

1
Band 1

What the Team is Known For

Yetter Coleman's group is noted for its extensive experience of advising clients in the burgeoning psychedelics space. The team are called upon to provide counsel on FDA and DEA regulatory submissions, as well as complex disputes in this space.

Work Highlights

  • Yetter Coleman represented the Advanced Integrative Medical Science Institute (AIMS) and Dr. Sunil Aggarwal in a lawsuit which challenged the DEA's refusal to allow psilocybin use for terminally ill patients under the Right to Try Act.

Strengths

Provided by Chambers

The Yetter Coleman team addresses complex matters with ease.

Psychedelics Law respondent
USA

They are an experienced team of attorneys and paralegals that provide valuable support.

Psychedelics Law respondent
USA